USANA Health Sciences, a company specializing in cellular nutrition, has released the findings of a 12-week consumer trial for its skincare supplement called Glow. This product offering is formulated to promote healthy, radiant-looking skin from within.
USANA Health Sciences' study reported that over 97% of participants experienced improvements in brightness, radiance, and evenness of skin tone, with more than 80% also noting better hydration, firmness, and elasticity. The trial involved 36 participants across the United States and Mexico, who assessed changes in their skin appearance over the duration of the study, and the results were consistent across both national groups.
Glow's formulation combines several key ingredients, including Damasty — which itself contains rose extract, bioactive melon superoxide dismutase, and acerola cherry vitamin C — alongside astaxanthin and grape seed oil.
Image Credit: USANA Health Sciences
What's Driving This Trend
- Ingestible Skincare
- Beauty routines are expanding beyond topical products as consumers seek supplement-based formulas that support visible skin outcomes through internal nutrition.
- Clinically Validated Glow
- Small-scale consumer trials and measurable appearance claims create differentiation for wellness brands competing in evidence-backed beauty categories.
- Antioxidant Beauty Blends
- Ingredient combinations featuring botanicals, vitamins, and carotenoids signal opportunities for multifunctional formulas positioned around radiance, hydration, and elasticity.
Who This Affects Most
- Beauty and Personal Care
- The category is being reshaped by hybrid products that connect skincare goals with nutrition-driven claims and daily supplement habits.
- Nutraceuticals
- Demand for targeted wellness benefits is supporting premium formulations that address cosmetic concerns through cellular health and antioxidant support.
- Health and Wellness
- Cross-border trial consistency highlights potential for scalable products that merge preventive self-care, beauty enhancement, and consumer-friendly clinical proof.
